ImipenemSALARIA, Manju.Indian pediatrics. 2001, Vol 38, Num 12, pp 1370-1373, issn 0019-6061Article

CarbapenemsBREILH, Dominique; TEXIER-MAUGEIN, Jeannette; ALLAOUCHICHE, Bernard et al.Journal of chemotherapy (Testo stampato). 2013, Vol 25, Num 1, pp 1-17, issn 1120-009X, 17 p.Article

Activity of faropenem against resistant isolates of Streptococcus pneumoniaeBLACK, Jennifer A; MOLAND, Ellen Smith; CHARTRAND, Stephen A et al.Diagnostic microbiology and infectious disease. 2001, Vol 41, Num 1-2, pp 89-92, issn 0732-8893Article

Carbapenems in serious infections : A risk-benefit assessmentNORRBY, S. R.Drug safety. 2000, Vol 22, Num 3, pp 191-194, issn 0114-5916Article

Multicenter evaluation of use of penicillin and ampicillin as surrogates for in vitro testing of susceptibility of enterococci to imipenemWEINSTEIN, Melvin P; MIRRETT, Stanley; KANNANGARA, Saman et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 8, pp 3747-3751, issn 0095-1137, 5 p.Article

Imipenem Disc for Detection of KPC Carbapenemase-Producing Enterobacteriaceae in Clinical PracticeBENENSON, Shmuel; TEMPER, Violeta; COHEN, Matan J et al.Journal of clinical microbiology (Print). 2011, Vol 49, Num 4, pp 1617-1620, issn 0095-1137, 4 p.Article

Detecting VIM-1 Production in Proteus mirabilis by an Imipenem-Dipicolinic Acid Double Disk Synergy TestMIRIAGOU, V; PAPAGIANNITSIS, C. C; TZELEPI, E et al.Journal of clinical microbiology (Print). 2010, Vol 48, Num 2, pp 667-668, issn 0095-1137, 2 p.Article

A copper-activated two-component system interacts with zinc and imipenem resistance in Pseudomonas aeruginosaCAILLE, Olivier; ROSSIER, Claude; PERRON, Karl et al.Journal of bacteriology. 2007, Vol 189, Num 13, pp 4561-4568, issn 0021-9193, 8 p.Article

Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniaePOIREL, Laurent; HERITIER, Claire; TOLÜN, Venus et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 1, pp 15-22, issn 0066-4804, 8 p.Article

Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: First report from IranABDOLAZIZ RASTEGAR LARI; AZIMI, Leila; RAHBAR, Mohammad et al.Burns. 2013, Vol 39, Num 1, pp 174-176, issn 0305-4179, 3 p.Article

The Pharmacokinetics and Pharmacodynamics of the Carbapenems: Focus on DoripenemMAZZEI, T.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 4, pp 219-225, issn 1120-009X, 7 p.Article

Current Status of Newer CarbapenemsBASSETTI, Matteo; NICOLINI, Laura; ESPOSITO, Silvano et al.Current medicinal chemistry. 2009, Vol 16, Num 5, pp 564-575, issn 0929-8673, 12 p.Article

Determination of imipenem and rifampicin in mouse plasma by high performance liquid chromatography-diode array detectionFERNANDEZ-TORRES, R; BELLO-LOPEZ, M. A; CALLEJON-MOCHON, M et al.Analytica chimica acta. 2008, Vol 608, Num 2, pp 204-210, issn 0003-2670, 7 p.Article

Integron-associated imipenem resistance in Acinetobacter baumannii isolated from a regional hospital in TaiwanLIU, S. Y; LIN, J. Y; CHU, C et al.International journal of antimicrobial agents. 2006, Vol 27, Num 1, pp 81-84, issn 0924-8579, 4 p.Article

Antibiotics improve survival in sepsis independent of injury severity but do not change mortality in mice with markedly elevated interleukin 6 levelsTURNBULL, Isaiah R; JAVADI, Pardis; BUCHMAN, Timothy G et al.Shock (Augusta, Ga.). 2004, Vol 21, Num 2, pp 121-125, issn 1073-2322, 5 p.Article

Clinical pharmacology of carbapenems in neonatesPACIFICI, Gian Maria; ALLEGAERT, Karel.Journal of chemotherapy (Testo stampato). 2014, Vol 26, Num 2, pp 67-73, issn 1120-009X, 7 p.Article

Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamaseDAHYOT, Sandrine; BROUTIN, Isabelle; DE CHAMPS, Christophe et al.FEMS microbiology letters. 2013, Vol 345, Num 2, pp 147-153, issn 0378-1097, 7 p.Article

Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamasesLEE, Kyungwon; CHANG KI KIM; ROSSOLINI, Gian Maria et al.International journal of antimicrobial agents (Print). 2010, Vol 36, Num 3, pp 259-263, issn 0924-8579, 5 p.Article

Parenteral carbapenemsSHAH, P. M.Clinical microbiology and infection. Supplement. 2008, Vol 14, Num 1, pp 175-180, issn 1470-9465, 6 p.Conference Paper

Imipenem: a potent inducer of multidrug resistance in Acinetobacter baumanniiKUO, Han-Yueh; CHANG, Kai-Chih; KUO, Jai-Wei et al.International journal of antimicrobial agents (Print). 2012, Vol 39, Num 1, pp 33-38, issn 0924-8579, 6 p.Article

Comparative activity of carbapenem testing: the COMPACT studyNORDMANN, Patrice; PICAZO, Juan J; MUTTERS, Reinier et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 5, pp 1070-1078, issn 0305-7453, 9 p.Article

Genetic and biochemical characterization of GES-5, an extended-spectrum class A β-lactamase from Klebsiella pneumoniaeIL KWON BAE; LEE, You-Nae; SEOK HOON JEONG et al.Diagnostic microbiology and infectious disease. 2007, Vol 58, Num 4, pp 465-468, issn 0732-8893, 4 p.Article

Imipenem heteroresistance induced by imipenem in multidrug-resistant Acinetobacter baumannii: mechanism and clinical implicationsLEE, Hao-Yuan; CHEN, Chyi-Liang; WANG, Shi-Bo et al.International journal of antimicrobial agents (Print). 2011, Vol 37, Num 4, pp 302-308, issn 0924-8579, 7 p.Article

The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological studyCARMELI, Yehuda; LIDJI, Shiri Klarfeld; SHABTAI, Esther et al.Diagnostic microbiology and infectious disease. 2011, Vol 70, Num 3, pp 367-372, issn 0732-8893, 6 p.Article

Doripenem: An Early Look at a Carbapenem Not Yet Approved for PediatricsOVERTURF, Gary D.The Pediatric infectious disease journal. 2010, Vol 29, Num 2, pp 163-165, issn 0891-3668, 3 p.Article